Researchers from The University of Texas Medical Branch at Galveston have received more than $7.7 million from the National Institute of Allergy & Infectious Diseases to spearhead a Center to identify, track and counter mosquito-borne diseases.

Galveston, Texas – The University of Texas Medical Branch at Galveston has been named to the IBM Watson Health 100 Top Hospitals list. Specifically, UTMB ranked in the top 15 nationwide among major teaching hospitals on the list. IBM Watson Health recognizes hospitals of all sizes in five different categories – major teaching hospitals, large community hospitals, medium community hospitals and smaller community hospitals.

Researchers from The University of Texas Medical Branch at Galveston explored the effects of estrogen and testosterone and their possible therapeutic effects in treating older patients with COVID-19. The findings are now available in Mayo Clinic Proceedings.

A team of researchers from The University of Texas Medical Branch at Galveston, led by Dr. George Saade, are active partners in the National Institutes of Health’s newly launched study to learn more about the impact of the COVID-19 pandemic on pregnancy and post-partum care.

A detailed study of the monoclonal antibodies from a person who survived a Marburg infection led researchers to identify novel mechanisms that contribute protection against the disease, according to the latest findings of a collaborative team led by The University of Texas Medical Branch at Galveston and Vanderbilt University Medical Center. The findings are now available in Cell Host & Microbe.